Default company panoramic image


GenQual develops companion diagnostics to improve treatment outcomes for autoimmune and oncology diseases.

  • Stage Product In Development
  • Industry Medical Devices and Equipment
  • Location Seattle, WA, USA
  • Currency USD
  • Founded August 2009
  • Employees 3
  • Website

Company Summary

GenQual develops companion diagnostics to stratify responders from non-responders and to determine appropriate dosage for very expensive drug therapies.

Our proof-of-concept stage diagnostics are designed as companion products for IL-6 and TNF-a mAb, and related biologics. We will sell our diagnostic kits to drug developers and CLIA laboratories. GenQual is ~70% subscribed in our current $250,000 Series AA Preferred funding round (7/2014)


  • 07897f78 6a33 4297 b3ed fbbba2d3142f
    Founder & CEO

    Founder & CEO of GenQual Corp. (2009-). Co-founder, Saga Software, Inc. (2011). Sr. QC Analyst, Targeted Genetics Corp. (2003-2009). Patent: "Methods of Prognosing and Administering Treatment for Inflammatory Disorders"(Intnl Pat No. PCT/US2012/024448) Specializes in novel product design and innovations, defining key market opportunities, identifying mutually beneficial partner strategies, assay optimization & validation, statistical analysis.

  • 24f5addf e871 46fb bd28 d62cb4f9c000
    COO & General Counsel

    Dr. Colton has broad technical and legal experience in the life science industry, including molecular diagnostics. He previously worked as a patent attorney managing domestic and international patents for corporations and research institutions. His scientific research includes genetic polymorphisms linked to vector-borne diseases such as malaria. He earned a Ph.D. from the University of Notre Dame and a J.D. from Brigham Young University.

  • Default avatar
    Dr. Ralph Paul
    co-Investigator and Technical Advisor

    Sr. Product Manager at Cerep and the Director of Technology Assessment and Discovery while at Targeted Genetics Corp. He currently serves at Abcam as a Scientific Support Supervisor. Dr. Paul received his Ph.D. in Molecular Virology at University of Calgary and he performed his post-doc studies in retrovirology at Oregon Health and Science University School of Medicine.


  • Default avatar
    Craig Sherman, JD; Wilson, Sonsini, Goodrich & Rosati
    Default avatar
    Howard S. Mendelsohn, BSc., CMA; CFO Selections

Previous Investors

  • Default avatar
    EB Caraway, Dr Rodney L Mirich, Jonathan Mirich, Rosalie Hodges